vs

Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and Ranger Energy Services, Inc. (RNGR). Click either name above to swap in a different company.

Esperion Therapeutics, Inc. is the larger business by last-quarter revenue ($168.4M vs $142.2M, roughly 1.2× Ranger Energy Services, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs -0.6%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs 1.9%).

Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.

Ranger Energy Services, Inc. is a leading North American onshore oilfield services provider. It offers a full suite of well completion, workover, rig operations, and production enhancement solutions for upstream oil and gas operators, primarily serving active unconventional shale and tight resource basins across the continental United States.

ESPR vs RNGR — Head-to-Head

Bigger by revenue
ESPR
ESPR
1.2× larger
ESPR
$168.4M
$142.2M
RNGR
Growing faster (revenue YoY)
ESPR
ESPR
+144.4% gap
ESPR
143.7%
-0.6%
RNGR
Faster 2-yr revenue CAGR
ESPR
ESPR
Annualised
ESPR
10.6%
1.9%
RNGR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ESPR
ESPR
RNGR
RNGR
Revenue
$168.4M
$142.2M
Net Profit
$3.2M
Gross Margin
Operating Margin
50.6%
2.3%
Net Margin
2.3%
Revenue YoY
143.7%
-0.6%
Net Profit YoY
-44.8%
EPS (diluted)
$0.32
$0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ESPR
ESPR
RNGR
RNGR
Q4 25
$168.4M
$142.2M
Q3 25
$87.3M
$128.9M
Q2 25
$82.4M
$140.6M
Q1 25
$65.0M
$135.2M
Q4 24
$69.1M
$143.1M
Q3 24
$51.6M
$153.0M
Q2 24
$73.8M
$138.1M
Q1 24
$137.7M
$136.9M
Net Profit
ESPR
ESPR
RNGR
RNGR
Q4 25
$3.2M
Q3 25
$-31.3M
$1.2M
Q2 25
$-12.7M
$7.3M
Q1 25
$-40.5M
$600.0K
Q4 24
$5.8M
Q3 24
$-29.5M
$8.7M
Q2 24
$-61.9M
$4.7M
Q1 24
$61.0M
$-800.0K
Operating Margin
ESPR
ESPR
RNGR
RNGR
Q4 25
50.6%
2.3%
Q3 25
-11.4%
2.0%
Q2 25
8.6%
6.1%
Q1 25
-34.0%
0.7%
Q4 24
-6.4%
6.2%
Q3 24
-31.0%
8.4%
Q2 24
3.5%
5.3%
Q1 24
52.5%
-0.4%
Net Margin
ESPR
ESPR
RNGR
RNGR
Q4 25
2.3%
Q3 25
-35.9%
0.9%
Q2 25
-15.4%
5.2%
Q1 25
-62.2%
0.4%
Q4 24
4.1%
Q3 24
-57.2%
5.7%
Q2 24
-83.9%
3.4%
Q1 24
44.3%
-0.6%
EPS (diluted)
ESPR
ESPR
RNGR
RNGR
Q4 25
$0.32
$0.14
Q3 25
$-0.16
$0.05
Q2 25
$-0.06
$0.32
Q1 25
$-0.21
$0.03
Q4 24
$-0.14
$0.24
Q3 24
$-0.15
$0.39
Q2 24
$-0.33
$0.21
Q1 24
$0.34
$-0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ESPR
ESPR
RNGR
RNGR
Cash + ST InvestmentsLiquidity on hand
$167.9M
$10.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$-302.0M
$300.1M
Total Assets
$465.9M
$419.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ESPR
ESPR
RNGR
RNGR
Q4 25
$167.9M
$10.3M
Q3 25
$92.4M
$45.2M
Q2 25
$86.1M
$48.9M
Q1 25
$114.6M
$40.3M
Q4 24
$144.8M
$40.9M
Q3 24
$144.7M
$14.8M
Q2 24
$189.3M
$8.7M
Q1 24
$226.6M
$11.1M
Total Debt
ESPR
ESPR
RNGR
RNGR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$0
Q3 24
$0
Q2 24
$0
Q1 24
$0
Stockholders' Equity
ESPR
ESPR
RNGR
RNGR
Q4 25
$-302.0M
$300.1M
Q3 25
$-451.4M
$270.0M
Q2 25
$-433.5M
$276.9M
Q1 25
$-426.2M
$272.6M
Q4 24
$-388.7M
$273.8M
Q3 24
$-370.2M
$267.6M
Q2 24
$-344.2M
$260.5M
Q1 24
$-294.3M
$261.7M
Total Assets
ESPR
ESPR
RNGR
RNGR
Q4 25
$465.9M
$419.3M
Q3 25
$364.0M
$372.8M
Q2 25
$347.1M
$381.7M
Q1 25
$324.0M
$376.5M
Q4 24
$343.8M
$381.6M
Q3 24
$314.1M
$373.9M
Q2 24
$352.3M
$359.6M
Q1 24
$373.1M
$355.5M
Debt / Equity
ESPR
ESPR
RNGR
RNGR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.00×
Q3 24
0.00×
Q2 24
0.00×
Q1 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ESPR
ESPR
RNGR
RNGR
Operating Cash FlowLast quarter
$45.2M
$24.1M
Free Cash FlowOCF − Capex
$17.1M
FCF MarginFCF / Revenue
12.0%
Capex IntensityCapex / Revenue
0.0%
4.9%
Cash ConversionOCF / Net Profit
7.53×
TTM Free Cash FlowTrailing 4 quarters
$42.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ESPR
ESPR
RNGR
RNGR
Q4 25
$45.2M
$24.1M
Q3 25
$-4.3M
$13.6M
Q2 25
$-31.4M
$20.7M
Q1 25
$-22.6M
$10.6M
Q4 24
$-35.0M
$32.7M
Q3 24
$-35.3M
$17.7M
Q2 24
$-7.2M
$22.1M
Q1 24
$53.8M
$12.0M
Free Cash Flow
ESPR
ESPR
RNGR
RNGR
Q4 25
$17.1M
Q3 25
$8.0M
Q2 25
$14.4M
Q1 25
$3.4M
Q4 24
$27.3M
Q3 24
$-35.5M
$10.8M
Q2 24
$-7.3M
$6.8M
Q1 24
$53.8M
$5.5M
FCF Margin
ESPR
ESPR
RNGR
RNGR
Q4 25
12.0%
Q3 25
6.2%
Q2 25
10.2%
Q1 25
2.5%
Q4 24
19.1%
Q3 24
-68.7%
7.1%
Q2 24
-9.9%
4.9%
Q1 24
39.0%
4.0%
Capex Intensity
ESPR
ESPR
RNGR
RNGR
Q4 25
0.0%
4.9%
Q3 25
0.0%
4.3%
Q2 25
0.0%
4.5%
Q1 25
0.0%
5.3%
Q4 24
0.0%
3.8%
Q3 24
0.3%
4.5%
Q2 24
0.1%
11.1%
Q1 24
0.1%
4.7%
Cash Conversion
ESPR
ESPR
RNGR
RNGR
Q4 25
7.53×
Q3 25
11.33×
Q2 25
2.84×
Q1 25
17.67×
Q4 24
5.64×
Q3 24
2.03×
Q2 24
4.70×
Q1 24
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ESPR
ESPR

Collaboration Revenue$124.7M74%
Products$43.7M26%

RNGR
RNGR

High Specification Rigs$92.3M65%
Processing Solutions And Ancillary Services$37.5M26%
Wireline Services$12.4M9%

Related Comparisons